INDIA BUSINESS WORLD - JANUARY 16th - JANUARY 31st
- 2008
AUROBINDO PHARMA GETS USFDA NOD FOR CEFDINIR
Pharmaceutical company Aurobindo Pharma has said that it has received approval from the US Food and Drug Administration (FDA) to market its 300 mg Cefdinir Capsules. The company said in a filing to the BSE that it has received US FDA approval to market its Abbreviated New Drug Application (ANDA) Cefdinir Capsules in the US market. Cefdinir is used to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. The drug is a generic equivalent of Abbott Laboratories Omnicef capsules.
|
